$90,000 of HONEYWELL INTERNATIONAL lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Transportation and FAA Appropriations. Defense/Aerospace Appropriations. General Energy Issues."
You can find more data on corporate lobbying on Quiver Quantitative.
HON Congressional Stock Trading
Members of Congress have traded $HON stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $HON stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARIA ELVIRA SALAZAR purchased up to $50,000 on 03/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
HON Insider Trading Activity
HON insiders have traded $HON stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $HON stock by insiders over the last 6 months:
- GRACE LIEBLEIN has made 0 purchases and 3 sales selling 5,847 shares for an estimated $1,425,089.
- ROBERT D. MAILLOUX (Vice President & Controller) sold 5,274 shares for an estimated $1,260,486
- D SCOTT DAVIS sold 2,367 shares for an estimated $568,080
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
HON Hedge Fund Activity
We have seen 1,063 institutional investors add shares of HON stock to their portfolio, and 1,239 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- J. STERN & CO. LLP removed 52,933,867 shares (-99.5%) from their portfolio in Q1 2026, for an estimated $11,964,641,958
- WELLINGTON MANAGEMENT GROUP LLP added 3,833,636 shares (+29.9%) to their portfolio in Q1 2026, for an estimated $866,516,745
- BLACKROCK, INC. removed 3,774,610 shares (-7.2%) from their portfolio in Q1 2026, for an estimated $853,175,098
- FRANKLIN RESOURCES INC added 3,318,104 shares (+32.4%) to their portfolio in Q1 2026, for an estimated $749,991,047
- SG AMERICAS SECURITIES, LLC removed 3,020,729 shares (-74.4%) from their portfolio in Q1 2026, for an estimated $682,775,375
- UBS GROUP AG removed 2,653,756 shares (-36.4%) from their portfolio in Q1 2026, for an estimated $599,828,468
- DIAMANT ASSET MANAGEMENT, INC. added 2,197,464 shares (+inf%) to their portfolio in Q1 2026, for an estimated $496,692,787
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
HON Analyst Ratings
Wall Street analysts have issued reports on $HON in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/30/2026
- JP Morgan issued a "Overweight" rating on 01/30/2026
To track analyst ratings and price targets for HON, check out Quiver Quantitative's $HON forecast page.
HON Price Targets
Multiple analysts have issued price targets for $HON recently. We have seen 15 analysts offer price targets for $HON in the last 6 months, with a median target of $260.0.
Here are some recent targets:
- Chigusa Katoku from JP Morgan set a target price of $250.0 on 07/07/2026
- Andrew Kaplowitz from Citigroup set a target price of $260.0 on 07/01/2026
- Jairam Nathan from Daiwa Capital set a target price of $255.0 on 06/30/2026
- Nicole Deblase from Deutsche Bank set a target price of $263.0 on 06/30/2026
- Chris Snyder from Morgan Stanley set a target price of $490.0 on 06/29/2026
- Deane Dray from RBC Capital set a target price of $275.0 on 06/11/2026
- Julian Mitchell from Barclays set a target price of $239.0 on 06/10/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
